These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 30859147)

  • 1. Levocarnitine Use Is Associated With Improvement in Sarcopenia in Patients With Liver Cirrhosis.
    Hiramatsu A; Aikata H; Uchikawa S; Ohya K; Kodama K; Nishida Y; Daijo K; Osawa M; Teraoka Y; Honda F; Inagaki Y; Morio K; Morio R; Fujino H; Nakahara T; Murakami E; Yamauchi M; Kawaoka T; Miki D; Tsuge M; Imamura M; Tanaka J; Chayama K
    Hepatol Commun; 2019 Mar; 3(3):348-355. PubMed ID: 30859147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Carnitine Supplementation on Hyperammonemia and Carnitine Deficiency Treated with Valproic Acid in a Psychiatric Setting.
    Nakamura M; Nagamine T
    Innov Clin Neurosci; 2015; 12(9-10):18-24. PubMed ID: 26634177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disturbed carnitine metabolism is independently correlated with sarcopenia and prognosis in patients on hemodialysis.
    Dai N; Diao Z; Huang H; Li Z; Yang R; Liu W
    Clin Nutr; 2024 Jul; 43(9):2019-2027. PubMed ID: 39068764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of levocarnitine administration in patients with chronic liver disease.
    Ohashi K; Ishikawa T; Hoshii A; Hokari T; Suzuki M; Noguchi H; Hirosawa H; Koyama F; Kobayashi M; Hirosawa S; Sugiyama K; Mitobe Y; Yoshida T
    Exp Ther Med; 2020 Nov; 20(5):94. PubMed ID: 32973943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: malnutrition/sarcopenia and frailty in patients with cirrhosis.
    Bunchorntavakul C; Reddy KR
    Aliment Pharmacol Ther; 2020 Jan; 51(1):64-77. PubMed ID: 31701570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features of liver cirrhosis patients with muscle cramping: a multicenter study.
    Hiraoka A; Yoshiji H; Iwasa M; Nakanishi H; Karino Y; Nakajima T; Miyaaki H; Shiraki M; Kawaguchi T; Sawada Y; Michitaka K; Okita K
    Eur J Gastroenterol Hepatol; 2019 Dec; 31(12):1557-1562. PubMed ID: 31180989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcopenia in cirrhosis: from pathogenesis to interventions.
    Ebadi M; Bhanji RA; Mazurak VC; Montano-Loza AJ
    J Gastroenterol; 2019 Oct; 54(10):845-859. PubMed ID: 31392488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiological-Based Nutritional Interventions in Cirrhotic Patients with Sarcopenic Obesity: A State-of-the-Art Narrative Review.
    Santangeli E; Abbati C; Chen R; Di Carlo A; Leoni S; Piscaglia F; Ferri S
    Nutrients; 2024 Jan; 16(3):. PubMed ID: 38337711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frailty in end-stage liver disease: Understanding pathophysiology, tools for assessment, and strategies for management.
    Elsheikh M; El Sabagh A; Mohamed IB; Bhongade M; Hassan MM; Jalal PK
    World J Gastroenterol; 2023 Dec; 29(46):6028-6048. PubMed ID: 38130738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of longitudinal changes in skeletal muscle mass with prognosis and nutritional intake in acutely hospitalized patients with abdominal trauma: a retrospective observational study.
    Xi F; You Y; Ding W; Gao T; Cao Y; Tan S; Yu W
    Front Nutr; 2023; 10():1085124. PubMed ID: 37324740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease.
    Musio A; Perazza F; Leoni L; Stefanini B; Dajti E; Menozzi R; Petroni ML; Colecchia A; Ravaioli F
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-carnitine prevents lenvatinib-induced muscle toxicity without impairment of the anti-angiogenic efficacy.
    Jing Z; Iba T; Naito H; Xu P; Morishige JI; Nagata N; Okubo H; Ando H
    Front Pharmacol; 2023; 14():1182788. PubMed ID: 37089945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carnitine derivatives beyond fatigue: an update.
    Malaguarnera M; Catania VE; Malaguarnera M
    Curr Opin Gastroenterol; 2023 Mar; 39(2):125-128. PubMed ID: 36821461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Significance of Zinc in Patients with Chronic Liver Disease.
    Nishikawa H; Asai A; Fukunishi S
    Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Systemic Therapies and Hepatic Arterial Infusion Chemotherapy in Patients with Advanced Hepatocellular Carcinoma Based on Sarcopenia Assessment.
    Yamasaki T; Saeki I; Yamauchi Y; Matsumoto T; Suehiro Y; Kawaoka T; Uchikawa S; Hiramatsu A; Aikata H; Kobayashi K; Kondo T; Ogasawara S; Chiba T; Takami T; Chayama K; Kato N; Sakaida I
    Liver Cancer; 2022 Jul; 11(4):329-340. PubMed ID: 35978601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rifaximin enhances the L‑carnitine‑mediated preventive effects on skeletal muscle atrophy in cirrhotic rats by modulating the gut‑liver‑muscle axis.
    Murata K; Kaji K; Nishimura N; Enomoto M; Fujimoto Y; Takeda S; Tsuji Y; Fujinaga Y; Takaya H; Kawaratani H; Namisaki T; Akahane T; Yoshiji H
    Int J Mol Med; 2022 Aug; 50(2):. PubMed ID: 35686541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levocarnitine Supplementation Suppresses Lenvatinib-Related Sarcopenia in Hepatocellular Carcinoma Patients: Results of a Propensity Score Analysis.
    Okubo H; Ando H; Nakadera E; Ikejima K; Shiina S; Nagahara A
    Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influencing Factors and Molecular Pathogenesis of Sarcopenia and Osteosarcopenia in Chronic Liver Disease.
    Saeki C; Tsubota A
    Life (Basel); 2021 Aug; 11(9):. PubMed ID: 34575048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High L-Carnitine Levels Impede Viral Control in Chronic Hepatitis B Virus Infection.
    Gu S; Fu X; Ye G; Chen C; Li X; Zhong S; Tang L; Chen H; Jiang D; Hou J; Li Y
    Front Immunol; 2021; 12():649197. PubMed ID: 34234772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases.
    Lai JC; Tandon P; Bernal W; Tapper EB; Ekong U; Dasarathy S; Carey EJ
    Hepatology; 2021 Sep; 74(3):1611-1644. PubMed ID: 34233031
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.